You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 3, March 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Dermatology
 •Dermatologic Disorders
 •Pain
 •Dermatologic Disorders, Other
 •Drug Therapy
 •Adverse Effects
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

VIGNETTES
Type 1 Leprosy Reaction Manifesting After Discontinuation of Adalimumab Therapy

Ivan D. Camacho, MD; Isabel Valencia, MD; Maria P. Rivas, MD; Anne E. Burdick, MD, MPH

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Report of a Case

A 47-year-old Brazilian man presented to the rheumatology clinic with a 6-month history of joint pain and swelling of both hands and wrists. His medical history was unremarkable. Laboratory studies revealed elevated C-reactive protein levels (3.6 mg/L; normal, <1.0 mg/L) and erythrocyte sedimentation rate (26 mm/h; normal range, 0-10 mm/h). (To convert C-reactive protein to nanomoles per liter, multiply by 9.524.) Findings were negative for anticyclic citrullinated peptide antibody, rheumatoid factor, and hepatitis B and C antibodies. On physical examination, symmetric polyarticular swelling of the hands and wrist joints was noted. Radiologic examination revealed diffuse soft-tissue swelling of the wrists. A presumptive diagnosis of seronegative rheumatoid arthritis was made, and treatment was begun with prednisone, 10 mg/d, and methotrexate, 20 mg/wk. Five months later, the symptoms persisted, and 2 subcutaneous doses of adalimumab, 40 . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.